Integrum AB (INTEG.B)

Overview

Integrum AB (publ) is a pioneering company focused on the research, development, and commercialization of innovative systems for bone-anchored prostheses. Established in 1962 and operating globally from its headquarters in Mölndal, Sweden, the organization has made significant strides in advancing prosthetic technologies. Dedicated to enhancing the quality of life for amputees, Integrum's solutions have been meticulously designed to integrate with the human body, promoting greater mobility and comfort. Through ongoing innovation and collaboration with medical professionals worldwide, the company has positioned itself as a leader in the field of osseointegrated prostheses.

Products and Services

Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) Implant Systems:

This flagship product represents a groundbreaking approach to prosthetic attachment, utilizing osseointegration to secure prostheses directly to bone. This technique eliminates the need for traditional sockets, offering amputees an unparalleled level of stability and comfort. The OPRA implant system is particularly noted for its ability to reduce the risk of bone fractures under accidental loads, providing users with a significant layer of protection and confidence in their mobility.

Neuromotus:

As a testament to Integrum's commitment to not only the physical but also the psychological well-being of amputees, Neuromotus is a cutting-edge therapy technology designed to alleviate phantom limb pain. This condition, common among amputee patients, can be a significant barrier to rehabilitation and quality of life. Neuromotus addresses this challenge with innovative solutions, offering new hope to those suffering from this often debilitating condition.